References
- Aderman CM, Schwartz DM. Acute bilateral vision loss. JAMA Ophthalmol. 2016;134(2):235–236.
- Omoti AE, Omoti CE, Momoh RO. Ocular disorders in adult leukemia patients in Nigeria. Middle East Afr J Ophthalmol. 2010;17(2):165–168.
- Eze BI, Ibegbulam GO, Ocheni S. Ophthalmic manifestations of leukemia in a tertiary hospital population of adult nigerian africans. Middle East Afr J Ophthalmol. 2010;17(4):325–329.
- Schachat AP, Markowitz JA, Guyer DR, et al. Ophthalmic manifestations of leukemia. Arch Ophthalmol. 1989;107(5):697–700.
- Goel N, Pangtey B, Thakar M, et al. Chronic myeloid leukemia presenting with bilateral central retinal vein occlusion and massive retinal infiltrates. J Aapos. 2012;16(4):406–408.
- Narang S, Gupta P, Sharma A, et al. Bilateral central retinal vein occlusion as presenting feature of chronic myeloid leukemia. Middle East Afr J Ophthalmol. 2016;23(3):253–255.
- Al-Abdulla NA, Thompson JT, LaBorwit SE. Simultaneous bilateral central retinal vein occlusion associated with anticardiolipin antibodies in leukemia. Am J Ophthalmol. 2001;132(2):266–268.
- El Fekih L, Hmaied W, Elhif S, et al. Chronic myeloid leukemia revealed by bilateral occlusion of the retinal central vein. Tunis Med. 2008;86(10):937–939.
- Bawankar P, Bhattacharjee H, Paulbuddhe V. Simultaneous bilateral central retinal vein occlusion as the first manifestation of chronic myeloid leukemia. Ophthalmol Retina. 2018;2(4):378.
- Wechsler DZ, Tay TS, McKay DL. Life-threatening haematological disorders presenting with opthalmic manifestations. Clin Experiment Ophthalmol. 2004;32(5):547–550.
- Swerdlow SH. International Agency for Research on Cancer., World Health Organization. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon, France: International Agency for Research on Cancer; 2008.
- Schiffer CL, Rosmarin AG. Hyperleukocytosis and leukostasis in hematologic malignancies. In: Post TE, ed. UpToDate. UpToDate, Waltham, MA. (Accessed on April 12, 2020).
- Uhr JH, Thau A, Chung C, et al. Rare presentation of bilateral central retinal vein occlusion and leukemic retinopathy in a young adult diagnosed with t-cell acute lymphoblastic leukemia. Cureus. 2020;12(1):e6666.
- Wong BJ, Berry JL. Acute lymphoblastic leukemia relapse presenting as optic nerve infiltration. JAMA Ophthalmol. 2017;135(1):e164656.
- Geringer J, Fenderson J, Osswald M. Essential thrombocythemia complicated by occlusive thrombosis of the abdominal aorta. Case Rep Hematol. 2019;2019:9454501.
- Rajagopal R, Apte RS. Seeing through thick and through thin: retinal manifestations of thrombophilic and hyperviscosity syndromes. Surv Ophthalmol. 2016;61(2):236–247.
- Sorigue M, Junca J, Orna E, et al. Retinal vein occlusion and paroxysmal nocturnal hemoglobinuria. J Thromb Thrombolysis. 2017;44(1):63–66.
- Hayreh SS, Zimmerman MB. Fundus changes in central retinal vein occlusion. Retina. 2015;35(1):29–42.
- Coscas G, Loewenstein A, Augustin A, et al. Management of retinal vein occlusion-consensus document. Ophthalmologica. 2011;226(1):4–28.
- Legros L, Bourcier C, Jacquel A, et al. Imatinib mesylate (STI571) decreases the vascular endothelial growth factor plasma concentration in patients with chronic myeloid leukemia. Blood. 2004;104(2):495–501.
- Mohamed M, Oakley C, McEwen F, et al. Leucapheresis for management of retinopathy in chronic myeloid leukaemia. BMJ Case Rep. 2015. DOI:10.1136/bcr-2015-212889